News | Imaging | December 10, 2015

Toshiba’s MRI Portfolio Is First to Meet Network Security Guidelines of the U.S. Department of Defense

Putting customers first by making security protection as the U.S. Armed Forces standard

Toshiba America Medical Systems, Inc. is the first manufacturer to have received authorization to operate (ATO) with the U.S. Air Force for its entire MR portfolio. Toshiba achieved ATO status for its Vantage Titan 1.5T and Vantage Titan 3T MR systems last year. This latest authorization includes its Vantage Elan 1.5T MR system.

By receiving ATO status, Toshiba’s MR systems have met the Air Force and Defense Health Agency’s (DHA) Platform Information Technology (PIT) guidelines for ensuring protection of Patient Health Information (PHI) and guarding against malware, viruses and malicious software. To meet these guidelines, Toshiba enhanced its MR platform to include Microsoft Windows 7 and application whitelisting security software to proactively identify and prevent viruses and malicious solicitations.

“The security of medical equipment and patient data is an extremely important issue in the healthcare industry,” said Guy Poloni, director, MR Business Unit, Toshiba. “This authorization is an example of how Toshiba continues to develop technology that meets our customers’ needs with a highly secure MR system.”

Select Toshiba CT systems have also recently received Air Force ATO. Toshiba highlighted its MR portfolio at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago.

For more information: www.medical.toshiba.com

Related Content

Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI) | September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
Siemens Healthineers to Showcase Magentom Vida MRI at RSNA 2017
Technology | Magnetic Resonance Imaging (MRI) | September 18, 2017
September 18, 2017 — Siemens Healthineers announced it will display the new Magnetom Vida 3T...
FDA Committee Votes to Expand Warning Labels on Gadolinium-Based Contrast Agents
News | Contrast Media | September 12, 2017
The U.S. Food and Drug Administration’s (FDA) Medical Imaging Drugs Advisory Committee (MIDAC) voted overwhelmingly...
News | Imaging | September 11, 2017
September 11, 2017 — Innovatus Imaging Corp., a newly created holding company formed by private equity firm Resilienc
Sponsored Content | Videos | Radiation Therapy | September 08, 2017
The new Visicoil MR is a helically-wound, flexible linear fiducial marker.
CIRS Launches New MRI Distortion Check Software
Technology | Magnetic Resonance Imaging (MRI) | September 06, 2017
MRI Distortion Check is a new, cloud-based solution designed to quickly and automatically quantify distortion in...
FDA Approves Guerbet's Dotarem for Pediatric Patients Younger Than Two Years
Technology | Magnetic Resonance Imaging (MRI) | September 06, 2017
September 6, 2017 — Guerbet LLC USA announced that the U.S.
Study Assesses Usefulness of MRI for Pediatric Sports-Related Concussion
News | Neuro Imaging | September 05, 2017
September 5, 2017 — A new study reviewed more than 5 years of records of...
The GE Healthcare Signa Premier MRI was among the top radiology stories from August 2017

The GE Healthcare Signa Premier MRI was among the top radiology stories from August 2017.

Feature | Imaging | September 01, 2017 | Melinda Taschetta-Millane
Here is the list of the most popular articles and videos on the Imaging Technology News (ITN) magazine website from the...
European Medicines Agency Issues Update on Gadolinium Contrast Agents
News | Contrast Media | August 29, 2017
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of
Overlay Init